These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30386103)

  • 1. Dimensions of hepatocellular carcinoma phenotypic diversity.
    Désert R; Nieto N; Musso O
    World J Gastroenterol; 2018 Oct; 24(40):4536-4547. PubMed ID: 30386103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection.
    Désert R; Rohart F; Canal F; Sicard M; Desille M; Renaud S; Turlin B; Bellaud P; Perret C; Clément B; Lê Cao KA; Musso O
    Hepatology; 2017 Nov; 66(5):1502-1518. PubMed ID: 28498607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Sia D; Villanueva A; Friedman SL; Llovet JM
    Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.
    Kurebayashi Y; Ojima H; Tsujikawa H; Kubota N; Maehara J; Abe Y; Kitago M; Shinoda M; Kitagawa Y; Sakamoto M
    Hepatology; 2018 Sep; 68(3):1025-1041. PubMed ID: 29603348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma.
    Zhang T; Gu J; Wang X; Lu Y; Cai K; Li H; Nie Y; Chen X; Wang J
    Front Immunol; 2023; 14():1140201. PubMed ID: 36936935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
    Wu PC; Fang JW; Lau VK; Lai CL; Lo CK; Lau JY
    Am J Pathol; 1996 Oct; 149(4):1167-75. PubMed ID: 8863666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on hepatocellular carcinoma: Pathologists' review.
    El Jabbour T; Lagana SM; Lee H
    World J Gastroenterol; 2019 Apr; 25(14):1653-1665. PubMed ID: 31011252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.
    Désert R; Mebarki S; Desille M; Sicard M; Lavergne E; Renaud S; Bergeat D; Sulpice L; Perret C; Turlin B; Clément B; Musso O
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):195-207. PubMed ID: 27545991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.
    Xia Y; Brown ZJ; Huang H; Tsung A
    Cancer Med; 2021 Sep; 10(18):6374-6383. PubMed ID: 34390203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
    Sia D; Jiao Y; Martinez-Quetglas I; Kuchuk O; Villacorta-Martin C; Castro de Moura M; Putra J; Camprecios G; Bassaganyas L; Akers N; Losic B; Waxman S; Thung SN; Mazzaferro V; Esteller M; Friedman SL; Schwartz M; Villanueva A; Llovet JM
    Gastroenterology; 2017 Sep; 153(3):812-826. PubMed ID: 28624577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications.
    Raja A; Haq F
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):15-29. PubMed ID: 34623518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
    Katoh H; Ojima H; Kokubu A; Saito S; Kondo T; Kosuge T; Hosoda F; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Gastroenterology; 2007 Nov; 133(5):1475-86. PubMed ID: 17983802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.
    Agosti P; Sabbà C; Mazzocca A
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):607-617. PubMed ID: 29197664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.
    Soto-Gutierrez A; Gough A; Vernetti LA; Taylor DL; Monga SP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1605-1616. PubMed ID: 28467181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.